SEC Form 4 · accession 0001415889-15-001026
ACADIA PHARMACEUTICALS INC · ACAD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel B Soland
Director
Period of report
Mar 20, 2015
Accepted (ET)
Mar 24, 2015 · 7:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070494
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $34.45 | Mar 20, 2015 | A | — | A | — | Mar 19, 2025 | Common Stock | — | — | D |
Explanation of responses
- F150% of the shares subject to the Stock Option vest and become exercisable on March 20, 2016 and 50% vest and become exercisable on March 20, 2017.